OctariusRx

FEBRUARY 20, 2023

The 2023 controlled substance assessment quiz is about to be released! This is our first annual competency assessment focused on controlled substances and regulatory compliance. The quiz focuses on some of the basic elements managing controlled substances. How are you assessing your staff?

Controlled Substances 79

Controlled Substances Documentation Compounding 79

The FDA Law Blog

FEBRUARY 28, 2023

Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. 13, 2023). By Larry K. Terrence L. Boos, Ph.D.,

Controlled Substances 56

Controlled Substances Compounding 56

OctariusRx

NOVEMBER 20, 2023

The 2023 version of the OctariusRx USP 800 assessment quiz is about to be released! With the enforcement of USP Chapter 800 beginning on November 1, 2023, facilities will be required to assess staff competency on an annual basis. The post The 2023 USP 800 Assessment Quiz appeared first on OctariusRX. Contact us for assistance.

Controlled Substances 86

Controlled Substances Compounding 86

The Happy PharmD

OCTOBER 11, 2024

Despite its substantial revenue of $24 billion in 2023, Rite Aid faced a steady decline leading to its eventual bankruptcy filing. Compounding its challenges, Rite Aid became entangled in legal issues, notably linked to the opioid crisis.

Controlled Substances 52

Controlled Substances Compounding 52

The FDA Law Blog

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).

Controlled Substances 52

Controlled Substances General Merchandise Stores Grocery Stores Compounding 52

The FDA Law Blog

JANUARY 18, 2024

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K.

FDA 67

FDA Controlled Substances Chemotherapy Compounding 67

The Checkup by Singlecare

MARCH 23, 2023

Understanding the difference between CBD vs. marijuana Cannabinoids are compounds found in the cannabis plant, Cannabis sativa. The United States Congress legalized CBD derived from hemp in 2018 when the Agricultural Improvement Act was signed into law, removing hemp from the Federal Controlled Substances Act.

Controlled Substances 52

Controlled Substances Medical Records Chemotherapy Compounding 52